Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Repligen Corporation (RGEN) vs West Pharmaceutical Services, Inc. (WST)

Repligen Corporation and West Pharmaceutical Services, Inc. are both Medical Instruments & Supplies companies. West Pharmaceutical Services, Inc. is the larger, with a market value of $26.3B against $10.8B — 2.4× the size. West Pharmaceutical Services, Inc. trades at the lower P/E: 47.1× against 253×. Repligen Corporation grew revenue faster over the last twelve months: 16.5% against 12.4%. West Pharmaceutical Services, Inc. has the higher net margin (17.0% vs 5.29%) and the higher return on invested capital (15.4% vs 2.18%). Across the 22 metrics below, West Pharmaceutical Services, Inc. leads on 14 and Repligen Corporation on 8.

Valuation

Metric RGEN WST Medical Instruments & Supplies median
P/E 252.91 47.07 34.17
P/S 13.63 7.88 2.83
P/B 5.07 8.77 2.82
Price to free cash flow 175.18 60.56 25.69
EV/EBITDA 65.28 30.16 16.08
EV/Sales 13.39 7.81 3.06
Earnings yield 0.40% 2.12% (1.84%)
Free cash flow yield 0.57% 1.65% 0.17%

Profitability

Metric RGEN WST Medical Instruments & Supplies median
Gross margin 53.52% 36.79% 54.62%
Operating margin 8.23% 20.45% 1.64%
Net margin 5.29% 16.98% 0.00%
Free cash flow margin 14.06% 13.13% 1.61%
Return on equity 1.99% 19.09% 0.00%
Return on assets 1.42% 14.07% 0.00%
Return on invested capital 2.18% 15.42% 0.00%

Growth

Metric RGEN WST Medical Instruments & Supplies median
Revenue growth (TTM) 16.49% 12.38% 9.20%
EPS growth (last fiscal year) 286.96% 1.49% —
Revenue growth, 5-year CAGR 15.05% 7.44% 9.48%
Net income growth, 5-year CAGR (3.99%) 7.36% 0.00%

Health

Metric RGEN WST Medical Instruments & Supplies median
Debt to equity 0.26 0.07 0.08
Current ratio 9.05 2.82 2.49
Net debt to EBITDA (1.50) (0.78) 0.83

Dividend

Metric RGEN WST Medical Instruments & Supplies median
Dividend yield — 0.14% 0.99%
Payout ratio 0.00 0.11 0.00

Size

Metric RGEN WST Medical Instruments & Supplies median
Market cap 10.76b 26.29b 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack